Advocate on issues related to transboundary animal disease monitoring, control, and prevention, including as it relates to avian influenza in animal agriculture. Monitor Administration's policy related to New World Screwworm. Educate Members of Congress and the Administration on Boehringer's capabilities to address emerging animal diseases. Monitor agriculture-related provisions in P.L.119-21, the One Big Beautiful Bill Act, and educate Members on Boehringer's priorities, including on animal disease prevention and response.
2025 · 4th Quarter (Oct 1 - Dec 31)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Filed by INVARIANT LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- INVARIANT LLC
- Filing UUID
- 77c50d98-ab74-47a3-94e8-c410a902f257
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.